<code id='8F325DFC7D'></code><style id='8F325DFC7D'></style>
    • <acronym id='8F325DFC7D'></acronym>
      <center id='8F325DFC7D'><center id='8F325DFC7D'><tfoot id='8F325DFC7D'></tfoot></center><abbr id='8F325DFC7D'><dir id='8F325DFC7D'><tfoot id='8F325DFC7D'></tfoot><noframes id='8F325DFC7D'>

    • <optgroup id='8F325DFC7D'><strike id='8F325DFC7D'><sup id='8F325DFC7D'></sup></strike><code id='8F325DFC7D'></code></optgroup>
        1. <b id='8F325DFC7D'><label id='8F325DFC7D'><select id='8F325DFC7D'><dt id='8F325DFC7D'><span id='8F325DFC7D'></span></dt></select></label></b><u id='8F325DFC7D'></u>
          <i id='8F325DFC7D'><strike id='8F325DFC7D'><tt id='8F325DFC7D'><pre id='8F325DFC7D'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:55621
          Daphne Koller -- biotech coverage from STAT
          Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

          New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

          Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

          advertisement

          But what exactly is Koller building?

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Ultragenyx gene therapy for rare liver ailment succeeds in late
          Ultragenyx gene therapy for rare liver ailment succeeds in late

          JonathanWiggs/GlobeStaffUltragenyxsaidThursdayafternoonthatitsgenetherapyforarareliverailment,glycog

          read more
          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more

          Boston competes with Raleigh

          PatGreenhouse/GlobeStaffMORRISVILLE,N.C.—TenminutesfromtheRaleighairport,thefutureofbiotechisunderco